Evidence map›Paper›PMID 35878085›Full record

Observational studyJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

A Population-Based Study of the Long-Term Risk of Infections Associated With Hospitalization in Childhood Cancer Survivors.

Leena Chehab, David R Doody, Adam J Esbenshade, Gregory M T Guilcher, Christopher C Dvorak, Brian T Fisher, Beth A Mueller, Eric J Chow, Jenna Rossoff

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Splenic function post radiation therapy in childhood cancer survivors.Clinical and translational radiation oncology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Leena ChehabDivision of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.
David R DoodyPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.ORCID 0000-0003-2291-6493
Adam J EsbenshadeVanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, TN.ORCID 0000-0002-0154-4996
Gregory M T GuilcherSection of Pediatric Oncology/Cellular Therapy, Departments of Oncology and Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Christopher C DvorakDivision of Pediatric Allergy, Immunology & Bone Marrow Transplantation, University of California San Francisco, San Francisco, CA.ORCID 0000-0002-6146-3952
Brian T FisherDivision of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA.ORCID 0000-0002-8224-4281
Beth A MuellerPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Eric J ChowPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.ORCID 0000-0001-7712-961X
Jenna RossoffDivision of Hematology/Oncology/Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.ORCID 0000-0003-0471-9883
Children's Hospital of Philadelphia · USFred Hutch Cancer Center · USAlexion Pharmaceuticals (France) · FRNorthwestern University · USUniversity of Calgary · CAUniversity of California, San Francisco · USUniversity of Washington · US

Funding

CANCER PREVENTION AND CONTROL PROGRAMS- REDUCE THE BURDEN OF CANCER IN WASHINGTONU58DP003899 · DP · WASHINGTON STATE DEPARTMENT OF HEALTH · PI JOYNER, PAMA · 2012 to 2014
$17.0M
NCCDPHP CDC HHS U58 DP003899NCI NIH HHS HHSN261201300012I
6 · The paper itself

Abstract

purposeInfections pose a significant risk during therapy for childhood cancer. However, little is known about the risk of infection in long-term survivors of childhood cancer.

methodsWe performed a retrospective observational study of children and adolescents born in Washington State diagnosed with cancer before age 20 years and who survived at least 5 years after diagnosis. Survivors were categorized as having a hematologic or nonhematologic malignancy and were matched to individuals without cancer in the state birth records by birth year and sex with a comparator:survivor ratio of 10:1. The primary outcome was incidence of any infection associated with a hospitalization using diagnostic codes from state hospital discharge records. Incidence was reported as a rate (IR) per 1,000 person-years. Multivariate Poisson regression was used to calculate incidence rate ratios (IRR) for cancer survivors versus comparators.

resultsOn the basis of 382 infection events among 3,152 survivors and 771 events among 31,519 comparators, the IR of all hospitalized infections starting 5 years after cancer diagnosis was 12.6 (95% CI, 11.4 to 13.9) and 2.4 (95% CI, 2.3 to 2.6), respectively, with an IRR 5.1 (95% CI, 4.5 to 5.8). The survivor IR during the 5- to 10-year (18.1, 95% CI, 15.9 to 20.5) and > 10-year postcancer diagnosis (8.3, 95% CI, 7.0 to 9.7) periods remained greater than comparison group IRs for the same time periods (2.3, 95% CI, 2.1 to 2.6 and 2.5, 95% CI, 2.3 to 2.8, respectively). When potentially vaccine-preventable infections were evaluated, survivors had a greater risk of infection relative to comparators (IRR, 13.1; 95% CI, 7.2 to 23.9).

conclusionInfectious complications continue to affect survivors of childhood cancer many years after initial diagnosis. Future studies are needed to better understand immune reconstitution to determine specific factors that may mitigate this risk.

Indexed as

Cancer SurvivorsNeoplasmsAdolescentAdultChildHospitalizationHumansRetrospective StudiesRisk FactorsSurvivorsYoung Adult

Identifiers

PMID35878085
PMCPMC9839247
OpenAlexW4287833514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.